Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone

被引:211
作者
Williams, KL [1 ]
Fuller, CR
Dieleman, LA
DaCosta, CM
Haldeman, KM
Sartor, RB
Lund, PK
机构
[1] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27599 USA
关键词
D O I
10.1053/gast.2001.22470
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Growth hormone (GH) is used as therapy for inflammatory bowel disease (IBD), but the specific effects on intestine are unknown. Transgenic mice overexpressing GH (MT1-bGH-TG) were used to test whether increased plasma GH levels alter inflammation or crypt damage during dextran sodium sulfate (DSS)induced colitis, Methods: MT1-bGH-TG and wild-type (WT) littermates were given 3% DSS for 5 days followed by up to 10 days of recovery, Colitis and epithelial cell proliferation were evaluated histologically. Plasma insulin-like growth factor (IGF)-I and colonic IGF-I, interleukin (IL)-1 beta, and intestinal trefoil factor (ITF) messenger RNAs (mRNAs) were measured. Results: DSS induced similar disease onset in MT1-bGH-TG and WT, More MT1-bGH-TG survived than WT. By recovery day 7, MT1-bGH-TG had less inflammation and crypt damage, elevated plasma IGF-I, and increased colonic ITF expression relative to WT. Colonic IL-1 beta was elevated in DSS-treated MT1-bGH-TG and WT, but IL-1 beta mRNA abundance correlated with disease only in WT, MT1-bGH-TG showed earlier increases in epithelial cell proliferation than WT during recovery but only WT showed atypical repair. Conclusions: GH does not alter susceptibility to acute DSS-induced colitis but enhances survival, remission of inflammation, and mucosal repair during recovery, GH therapy may be beneficial during active IBD by improving mucosal repair.
引用
收藏
页码:925 / 937
页数:13
相关论文
共 42 条
  • [21] PODOLSKY DK, 1999, AM J PHYSIOL, V277, pG495
  • [22] IGF-I and procollagen α1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease
    Pucilowska, JB
    McNaughton, KK
    Mohapatra, NK
    Hoyt, EC
    Zimmermann, EM
    Sartor, RB
    Lund, PK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2000, 279 (06): : G1307 - G1322
  • [23] SARTOR RB, 1995, GASTROENTEROL CLIN N, V24, P475
  • [24] Growth in Crohn's disease
    Savage, MO
    Beattie, RM
    Camacho-Hübner, C
    Walker-Smith, JA
    Sanderson, IR
    [J]. ACTA PAEDIATRICA, 1999, 88 : 89 - 92
  • [25] Fasting prevents experimental murine colitis produced by dextran sulfate sodium and decreases interleukin-1 beta and insulin-like growth factor I messenger ribonucleic acid
    Savendahl, L
    Underwood, LE
    Haldeman, KM
    Ulshen, MH
    Lund, PK
    [J]. ENDOCRINOLOGY, 1997, 138 (02) : 734 - 740
  • [26] Sax H C, 1996, JPEN J Parenter Enteral Nutr, V20, P375, DOI 10.1177/0148607196020005375
  • [27] Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: A randomized, controlled study
    Scolapio, JS
    Camilleri, M
    Fleming, CR
    Oenning, LV
    Burton, DD
    Sebo, TJ
    Batts, KP
    Kelly, DG
    [J]. GASTROENTEROLOGY, 1997, 113 (04) : 1074 - 1081
  • [28] EFFECTS OF SHORT-TERM GROWTH-HORMONE THERAPY IN RATS UNDERGOING 75-PERCENT SMALL INTESTINAL RESECTION
    SHULMAN, DI
    HU, CS
    DUCKETT, G
    LAVALLEEGREY, M
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1992, 14 (01) : 3 - 11
  • [29] INSULIN-LIKE GROWTH-FACTOR-I AND EPIDERMAL GROWTH-FACTOR INTERACT TO REGULATE GROWTH AND GENE-EXPRESSION IN IEC-6 INTESTINAL EPITHELIAL-CELLS
    SIMMONS, JG
    HOYT, EC
    WESTWICK, JK
    BRENNER, DA
    PUCILOWSKA, JB
    LUND, PK
    [J]. MOLECULAR ENDOCRINOLOGY, 1995, 9 (09) : 1157 - 1165
  • [30] A preliminary study of growth hormone therapy for Crohn's disease
    Slonim, AE
    Bulone, L
    Damore, MB
    Goldberg, T
    Wingertzahn, MA
    McKinley, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (22) : 1633 - 1637